Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the Fibrosis Panel on the Evaluation of Allograft Fibrosis After Pediatric Liver Transplantation

NCT05308628 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT05308628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05308628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the Fibrosis Panel on the Evaluation of Allograft Fibrosis After Pediatric Liver Transplantation
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 30, 2022
Completion date
November 30, 2025
Enrollment
1,200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver fibrosis, liver transplant; complications, pediatric disorder